Sunny Biodiscovery, Inc.

Santa Clara, CA 95050

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $1.52MM
First Award Date 03/27/00
Most Recent Award Date 09/01/13

Key Personnel

Last Name Name Awards Contact
Bojanowski Krys Bojanowski 3
Zhao Hui Zhao 5

8 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/13 - 08/31/14

DESCRIPTION (provided by applicant): Psoriasis is a chronic skin disease affecting 2% of the world population. It is characterized by immune infiltrates in lesions and hyperkeratosis, and can be partially remediated with prescription medicines, such as topical retinoids. Despite their great potential, current topical retinoid drugs are typically...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/07 - 05/31/09
PI: Hui Zhao

DESCRIPTION (provided by applicant): Our society becomes increasingly vulnerable to chronic wounds as we age and become more obese. Despite that, efficient, inexpensive and simple-to-apply wound-healing drugs are presently unavailable. Here, we initiated the development of such a drug. In Phase I we demonstrated the superior wound-healing activi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/06 - 05/31/07
PI: Hui Zhao

DESCRIPTION (provided by applicant): Our society becomes increasingly vulnerable to chronic wounds as we age and become more obese. Despite that, efficient, inexpensive and simple-to-apply wound-healing drugs are presently unavailable. Here, we initiated the development of such a drug. In Phase I we demonstrated the superior wound-healing activi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/06/05 - 09/05/06

DESCRIPTION (provided by applicant): Therapeutic angiogenesis is a new experimental approach to ischemic heart disease. It consists on inducing the growth of collateral blood vessels in ischemic areas of the myocardium. Currently, therapeutic angiogenesis focuses on gene therapy with angiogenic proteins such as DEL-1, VEGF and FGF. Besides facin...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/04 - 12/31/04
PI: Hui Zhao

DESCRIPTION: Periodontitis is the major cause of teeth motility and loss. Twenty percent of adult Americans suffer severe periodontitis, resulting in destruction of the supporting structures of teeth, including the alveolar bone. Periodontal surgery can slow the progression of the disease, but is costly, limited by contraindications, often requi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/03 - 08/31/04
PI: Hui Zhao

DESCRIPTION (provided by applicant): Chronic wounds translate into daily suffering for 7 million elderly people in United States and Europe alone. Modern dressings, as used today, are insufficient for optimal treatment of these wounds because most often they do not include compounds actively promoting wound healing. Stimulation of angiogenesi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-91
Budget: 06/01/02 - 10/31/03

Inhibition of tumor angiogenesis-the growth of new blood vessels towards the tumor mass-is a new and promising approach to anti-cancer therapy. The results of Phase I/II clinical trials completed so far with several angiogenesis inhibitors validate the concept of tumor angiogenesis as effective target for anti-cancer therapy. However, the same ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/27/00 - 03/26/01
PI: Hui Zhao

Inhibition of tumor angiogenesis (the growth of blood vessels towards the tumor mass) is a new, promising approach to the anti-cancer therapy. Inhibitors of angiogenesis such as angiostatin purified from urine of tumor- bearing mice have a potent antineoplastic activity in rodents. Therefore, we propose that angiogenesis inhibitors purified fro...